This update includes comment from Beckman Coulter.

NEW YORK (GenomeWeb News) — An arbitration panel has ruled that Beckman Coulter violated the terms of an original cross-license agreement between Institute Pasteur and Digene when it sold its human papillomavirus intellectual property to Ventana, Digene announced today.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.